Managing Your Genetic Health
search
Home
Corporate
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Shareholder Information
Corporate Governance
Shareholder Meetings & List
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Medical
Overview
Breast & Ovarian Cancer
Bowel & Uterine Cancer
Neurogenetics
Epilepsy
Forensics
Overview
Presumptive & Confirmatory Testing
Individual DNA Profiling
Species Identification
Animal Forensic Testing
Paternity
Legal - Paternity
Non Legal - Paternity
Legal Practitioners
Antenatal
Deceased Estate
DNA In A Day
Sibship
Twins
Y – Chromosome
DNA Profiling
Grandparent
Immigration
Personal
Overview
Sports Performance
Ancestry
Animals
DNA Testing
BITSA
Animal Forensics
Plants
Genomic Services
Xpress Sequencing
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Shareholder Information
Corporate Governance
Shareholder Meetings & List
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Announcements
Gen-Probe License
03 May 2010
Gen-Probe License
Acquisition of BREVAGen
14 April 2010
Acquisition of BREVAGen
Private placement of shares and ASX Appendix 3B
14 April 2010
Private placement of shares and ASX Appendix 3B
GTG Investor Update - March 2010
31 March 2010
GTG Investor Update - March 2010
NASDAQ press release - 16 March 2010 Marketplace Rule 5810(b)
16 March 2010
NASDAQ press release - 16 March 2010 Marketplace Rule 5810(b)
Previous Announcements
Expiry of options - 2 March 2010
ASX Appendix 4D - 31 December 2009 with Financial Report
Assertion of property rights
BioBusiness TV - GTG
Lodgement of Appendix 4C
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 3 of 15
Latest News
ASX Appendix 4E - 30 June 2010
Monsanto license - August 2010
ASX Quarterly Reports - 30 June 2010
Share Price